Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2026-01-02 @ 2:26 AM
Study NCT ID:
NCT05477095
Status:
COMPLETED
Last Update Posted:
2025-03-12
First Post:
2022-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants
Sponsor:
Vaxxinity, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-06
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-20
First Submit QC Date:
None
Study First Post Date:
2022-07-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-13
Results First Submit QC Date:
None
Results First Post Date:
2025-03-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-05
Last Update Post Date:
2025-03-12
Last Update Post Date Type:
ACTUAL